A019
REPRODUCTIVE FACTORS, OBESITY, AND RISK OF THYROID CANCER AMONG WOMEN: A MULTICENTER RESEARCH NETWORK ANALYSIS
Endocrine Surgery
Madison N Hearn, BS; Neerav Goyal, MD, MPH; Tonya King, PhD; David Goldenberg, MD, FACS
Penn State College of Medicine
A020
ANAPLASTIC THYROID CANCER MANAGEMENT AND OUTCOMES: 20-YEAR SINGLE INSTITUTION EXPERIENCE
Shannon S Wu1; Eric Lamarre, MD2; Anirudh Yalamanchali, MD, MS2; Philip Brauer3; Chandana A Reddy2; Emrullah Yilmaz, MD2; Neil Woody, MD2; Jamie Ku, MD2; Brandon Prendes, MD2; Christian Nasr, MD2; Mario Skugor, MD2; Katherine Heiden, MD2; Deborah Chute, MD2; Jeffrey Knauf, PhD4; Shauna R Campbell, DO2; Shlomo Koyfman, MD2; Jessica Geiger, MD2; Joseph Scharpf, MD2
1Cleveland Clinic Lerner College of Medicine; 2Head and Neck Institute, Cleveland Clinic; 3Case Western Reserve University School of Medicine; 4Lerner Research Institute, Cleveland Clinic
A021
TRANSORAL ENDOSCOPIC THYROIDECTOMY VIA THE VESTIBULAR APPROACH (TOETVA) IN PATIENTS WITH GRAVES' DISEASE: A NORTH AMERICAN CASE SERIES
Katherine Tai1; Sallie Long, MD1; Victoria Yu, MD1; Rachel Weitzman1; Victoria Banuchi, MD1; Jonathon Russell, MD2
1Weill Cornell Medicine Otolaryngology Head and Neck Surgery; 2Johns Hopkins Otolaryngology-Head and Neck Surgery
A022
RISK STRATIFICATION OF LATERAL NECK RECURRENCE FOR PN1A PAPILLARY THYROID CANCER BASED ON THE NUMBER OF CENTRAL METASTATIC LYMPH NODES AND PRIMARY TUMOR SIZE
Siyuan Xu; Hui Huang; Shaoyan Liu; Jie Liu
Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A023
NEOADJUVANT SELECTIVE RET INHIBITOR FOR MEDULLARY THYROID CANCER: A CASE SERIES
Kevin J Contrera, MD, MPH; Maria K Gule-Monroe, MD; Maria E Cabanillas, MD; Mimi I Hu, MD; Naifa L Busaidy, MD; Ramona Dadu, MD; Steven G Waguespack, MD; Jennifer Wang, MD; Jeffery Myers, MD, PhD; Elizabeth G Grubbs, MD; Vivek Subbiah, MD; Michelle D Williams, MD; Mark E Zafereo, MD
UT MD Anderson Cancer Center
A024
SHARED DECISION-MAKING IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES
David Forner, MD, MSc1; Victoria Taylor, BA1; Christopher W Noel, MD2; Brooke Turner, MD1; Paul Hong, MD, MSc1; Stephanie Johnson-Obaseki, MD, MPH3; David P Goldstein, MD, MSc2; Matthew H Rigby, MD, MPH1; S. Mark Taylor, MD1; Jonathan R Trites, MD1; Martin Corsten, MD1
1Dalhousie University; 2University of Toronto; 3University of Ottawa
A025
HEALTH CARE DISPARITIES AND RATES OF MALIGNANCY AMONGST CHILDREN WITH SINGLE THYROID NODULES
Z. Jason Qian, MD1; Eric Pineda, BS2; Hilary Seeley, MD1; Gary Hartman, MD1; Julia Noel, MD1; Lisa A Orloff, MD1; Kara D Meister, MD1
1Stanford University; 2Tulane University
A026
COMPARISON OF RISK FACTORS AND POSTOPERATIVE OUTCOMES IN PRIMARY AND SECONDARY/TERTIARY HYPERPARATHYROIDISM
Ryan M Kong, BS; Jennifer Liang, MD; Natalya Chernichenko, MD
SUNY Downstate Health Sciences University
A027
FACTORS ASSOCIATED WITH REFUSAL OF SURGERY IN DIFFERENTIATED THYROID CARCINOMA
Aman Prasad, BS1; Ryan M Carey, MD2; Robert M Brody, MD2; Steven B Cannady, MD2; Jason G Newman, MD2; Jason Brant, MD2; Karthik Rajasekaran, MD2
1Perelman School of Medicine at the University of Pennsylvania; 2Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine
AHNS26
THE VALUE OF SECOND OPINIONS ON THYROID NODULE MANAGEMENT PROVIDED VIA DIRECT-TO-CONSUMER TELEMEDICINE SERVICE
Samuel Dudley, MD; Marion B Gillespie, MD
University of Tennessee Health Science Center
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX